4.6 Article

MYCN mRNA degradation and cancer suppression by a selective small-molecule inhibitor in MYCN-amplified neuroblastoma

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Review Oncology

MYCN Impact on High-Risk Neuroblastoma: From Diagnosis and Prognosis to Targeted Treatment

Damiano Bartolucci et al.

Summary: Neuroblastoma is one of the most deadly cancers in children, with high-risk neuroblastoma (HR-NB) showing a very aggressive pattern and poor prognosis. The review focuses on the role of MYCN in HR-NB and highlights the current knowledge in diagnosis, prognosis, and therapeutic approaches. MYCN is considered a highly relevant target for HR-NB patient management, and new therapies targeting it are being proposed.

CANCERS (2022)

Article Medicine, Research & Experimental

MYCN in Neuroblastoma: Old Wine into New Wineskins

Maria Braoudaki et al.

Summary: MYCN Proto-Oncogene, BHLH Transcription Factor is a well-studied gene in neuroblastoma with oncogenetic mechanisms and a key role in the disease's prognosis. It is considered a prominent target for therapy. MYCN's functions in neuroblastoma biology range from forming G-quadruplexes to regulating gene methylation and histone acetylation. Further research is needed to fully understand MYCN's amplification mechanisms and potential interventions for neuroblastoma treatment.

DISEASES (2021)

Article Biochemistry & Molecular Biology

Anti-cancer effect of oncolytic adenovirus-armed shRNA targeting MYCN gene on doxorubicin-resistant neuroblastoma cells

Yuan Li et al.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2017)

Article Multidisciplinary Sciences

Multiple mechanisms disrupt the let-7 microRNA family in neuroblastoma

John T. Powers et al.

NATURE (2016)

Article Biochemistry & Molecular Biology

Inhibition of MDM2 homodimerization by XIAP IRES stabilizes MDM2, influencing cancer cell survival

Tao Liu et al.

MOLECULAR CANCER (2015)

Article Medicine, Research & Experimental

Neuroblastoma and MYCN

Miller Huang et al.

COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2013)

Article Genetics & Heredity

LIN28B induces neuroblastoma and enhances MYCN levels via let-7 suppression

Jan J. Molenaar et al.

NATURE GENETICS (2012)

Article Biochemistry & Molecular Biology

MDM2 regulates MYCN mRNA stabilization and translation in human neuroblastoma cells

L. Gu et al.

ONCOGENE (2012)

Article Biochemistry & Molecular Biology

MDM2 Regulates Vascular Endothelial Growth Factor mRNA Stabilization in Hypoxia

Sheng Zhou et al.

MOLECULAR AND CELLULAR BIOLOGY (2011)

Article Oncology

p53 Is a Direct Transcriptional Target of MYCN in Neuroblastoma

Lindi Chen et al.

CANCER RESEARCH (2010)

Article Cell Biology

p53 mrNA controls p53 activity by managing Mdm2 functions

Marco M. Candeias et al.

NATURE CELL BIOLOGY (2008)

Article Cell Biology

The tumor suppressor microRNA let-7 represses the HMGA2 oncogene

Yong Sun Lee et al.

GENES & DEVELOPMENT (2007)

Article Biochemical Research Methods

Clonogenic assay of cells in vitro

Nicolaas A. P. Franken et al.

NATURE PROTOCOLS (2006)

Article Multidisciplinary Sciences

The p53 regulatory gene MDM2 is a direct transcriptional target of MYCN in neuroblastoma

A Slack et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)